logo

For the Inventor, By the Inventor

L′ile-Bizard, Canada

Claudio F Sturino

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 7.8

ph-index = 7

Forward Citations = 172(Granted Patents)


Location History:

  • Dorval, CA (2002)
  • L′ile-Bizard, CA (2009)
  • Laval, CA (2013)
  • Ile-Bizard, CA (2011 - 2018)
  • L'ile-Bizard, CA (2007 - 2019)
  • Montreal, CA (2020 - 2023)

Company Filing History:

goldMedal6 out of 3,223 
 
Genentech, Inc.
 patents
silverMedal5 out of 80 
 
Merck Frosst Canada & Co.
 patents
bronzeMedal5 out of 1,152 
 
Vertex Pharmaceuticals, Inc.
 patents
4. 2 out of 1,537 
 
Boehringer Ingelheim International Gmbh
 patents
5. 2 out of 2 
 
Merck Frosst Company
 patents
6. 1 out of 109 
 
Xenon Pharmaceuticals Inc.
 patents
7. 1 out of 40 
 
Merck Canada Inc.
 patents
8. 1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
9. 1 out of 212 
 
Merck Frosst Canada, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents
1. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-06-10),
2. 12281102 - Inhibitors of APOL1 and methods of using same (2025-04-21),
3. 12269831 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-04-08),
4. 12202824 - Oxadiazole transient receptor potential channel inhibitors (2025-01-21),
5. 12116343 - Inhibitors of APOL1 and methods of using same (2024-10-15),
6. 11655245 - Oxadiazole transient receptor potential channel inhibitors (2023-05-23),
7. 11208387 - Macrocyclic broad spectrum antibiotics (2021-12-28),
8. 11028075 - Therapeutic compounds and methods of use thereof (2021-06-08),
9. 10710994 - Oxadiazole transient receptor potential channel inhibitors (2020-07-14),
10. 10457654 - Therapeutic compounds and methods of use thereof (2019-10-29),
11. 10030024 - Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway (2018-07-24),
12. 9399645 - Inhibitors of HIV replication (2016-07-26),
13. 8685999 - Beta carboline sulphonylurea derivatives as EP4 receptor antagonists (2014-04-01),
14. 8349839 - Inhibitors of HIV replication (2013-01-08),
15. 8003661 - Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists (2011-08-23),

Title: Claudio F Sturino - Pioneering Inventor from L′ile-Bizard, CA

Introduction: Claudio F Sturino is a distinguished inventor hailing from L′ile-Bizard, Canada, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Claudio F Sturino holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his illustrious career, Claudio F Sturino has consistently pushed the boundaries of innovation, with a keen focus on developing cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Claudio F Sturino has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration in the tech community.

Conclusion: Claudio F Sturino's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his reputation as a visionary inventor in the vibrant landscape of Canadian innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…